184 related articles for article (PubMed ID: 34148050)
41. Screening for Myositis Antibodies in Idiopathic Interstitial Lung Disease.
Fidler L; Doubelt I; Kandel S; Fisher JH; Mittoo S; Shapera S
Lung; 2019 Jun; 197(3):277-284. PubMed ID: 30838434
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic implications of positive avian serology in suspected hypersensitivity pneumonitis.
Woge MJ; Ryu JH; Moua T
Respir Med; 2017 Aug; 129():173-178. PubMed ID: 28732828
[TBL] [Abstract][Full Text] [Related]
43. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
44. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
45. Myositis Antibodies and Interstitial Lung Disease.
Basuita M; Fidler LM
J Appl Lab Med; 2022 Jan; 7(1):240-258. PubMed ID: 34996093
[TBL] [Abstract][Full Text] [Related]
46. Interstitial Lung Diseases in Developing Countries.
Rivera-Ortega P; Molina-Molina M
Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741505
[TBL] [Abstract][Full Text] [Related]
47. Dyspnea in a patient with Raynaud's phenomenon: the uncovering of interstitial lung disease.
Coates A; Meehan R; Milla C
Pediatr Pulmonol; 2012 Sep; 47(9):926-7. PubMed ID: 22467473
[TBL] [Abstract][Full Text] [Related]
48. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120
[TBL] [Abstract][Full Text] [Related]
49. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
[TBL] [Abstract][Full Text] [Related]
50. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
51. Increased prevalence of high anti-Cladosporium antibody titers in interstitial lung diseases.
Watanuki Z; Okada S; Chiba S; Kamei K; Suzuki Y; Yamada N
Tohoku J Exp Med; 2012 Apr; 226(4):287-91. PubMed ID: 22499120
[TBL] [Abstract][Full Text] [Related]
52. [Diffuse infiltrating lung disease secondary to antisynthetase syndrome: a case report].
Moussa N; Khemakhem R; Snoussi M; Fekih W; Bahloul Z; Kammoun S
Pan Afr Med J; 2021; 39():30. PubMed ID: 34394821
[TBL] [Abstract][Full Text] [Related]
53. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
54. The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.
Cotton CV; Spencer LG; New RP; Cooper RG
Rheumatology (Oxford); 2017 Aug; 56(8):1264-1271. PubMed ID: 28339528
[TBL] [Abstract][Full Text] [Related]
55. [Update on interstitial lung diseases].
Salinas M; Florenzano M; Wolff V; Rodríguez JC; Valenzuela H; Fernández C; Undurraga Á
Rev Med Chil; 2019 Nov; 147(11):1458-1467. PubMed ID: 32186607
[TBL] [Abstract][Full Text] [Related]
56. State-of-the-Art Imaging of the Lung for Connective Tissue Disease (CTD).
Ohno Y; Koyama H; Yoshikawa T; Seki S
Curr Rheumatol Rep; 2015 Dec; 17(12):69. PubMed ID: 26483318
[TBL] [Abstract][Full Text] [Related]
57. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of Interstitial Lung Disease Caused by Possible Hypersensitivity Pneumonitis in a Child: Think CGD.
Esenboga S; Emiralioglu N; Cagdas D; Erman B; De Boer M; Oguz B; Kiper N; Tezcan İ
J Clin Immunol; 2017 Apr; 37(3):269-272. PubMed ID: 28224353
[TBL] [Abstract][Full Text] [Related]
59. Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders.
Cramer C; Schlünssen V; Bendstrup E; Stokholm ZA; Vestergaard JM; Frydenberg M; Kolstad HA
Eur Respir J; 2016 Sep; 48(3):818-25. PubMed ID: 27230447
[TBL] [Abstract][Full Text] [Related]
60. Organic antigen-induced interstitial lung disease: diagnosis and management.
Jacobs RL; Andrews CP; Coalson J
Ann Allergy Asthma Immunol; 2002 Jan; 88(1):30-41. PubMed ID: 11814275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
